Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database

BACKGROUND: There is variability in the prognosis of stage III-N2 lung adenocarcinoma (LUAD) patients. The current tumor-node-metastasis (TNM) staging is not sufficient to precisely estimate the prognosis of stage III-N2 LUAD patients. The Surveillance, Epidemiology, and End Results (SEER) database...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shengchao, Xiao, Xiangzhi, Qin, Xuan, Xia, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643949/
https://www.ncbi.nlm.nih.gov/pubmed/37969392
http://dx.doi.org/10.21037/tcr-22-2757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643949/
https://www.ncbi.nlm.nih.gov/pubmed/37969392
http://dx.doi.org/10.21037/tcr-22-2757

Ejemplares similares